Neochem Bio Solutions has submitted Statement of Investor Grievances under Reg13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2026|SUBJECT: Integrated Filing- Governance
Source link